Scopus by Title (Ref)

Network pharmacology and molecular docking reveal antiviral mechanisms of silver nanoparticles synthesized by Oscillatoria sp. against HCV pathogenesis

Scientific Reports

December 2025

Azmy L.

Open Access

Hepatitis c virus prevalence and risk factors in a village in northeastern romania—a population-based screening—the first step to viral micro-elimination

Healthcare Switzerland

June 2021

Huiban L.

Open Access

An update on direct antiviral agents for the treatment of hepatitis C

Expert Opinion on Pharmacotherapy

2021

Stanciu C.

Liver remodeling on ct examination in patients with hcv compensated cirrhosis who achieved sustained virological response after direct-acting antivirals treatment

Medicina Lithuania

April 2020

Mihai F.

Open Access

Efficacy and safety of alisporivir for the treatment of hepatitis C infection

Expert Opinion on Pharmacotherapy

4 March 2019

Stanciu C.

High prevalence of nonalcoholic steatohepatitis and abnormal liver stiffness in a young and obese Mexican population

Plos One

January 2019

Sepulveda-Villegas M.

Open Access

Real-world efficacy and safety of ombitasvir, paritaprevir/r+dasabuvir+ribavirin in genotype 1b patients with hepatitis C virus cirrhosis

Liver International

April 2018

Preda C.M.

New epidemiologic data regarding hepatitis C virus infection in Romania

Journal of Gastrointestinal and Liver Diseases

December 2017

Manuc M.

Open Access

Limiting the access to direct-acting antivirals against HCV: an ethical dilemma

Expert Review of Gastroenterology and Hepatology

1 November 2016

Gentile I.

Need of righteous attitudes towards eradication of hepatitis C virus infection in Latin America

World Journal of Gastroenterology

14 June 2016

Panduro A.

Open Access

High risk of infection during triple therapy with first- generation protease inhibitors: A nationwide cohort study

Journal of Gastrointestinal and Liver Diseases

June 2016

Berden F.A.C.